Products
Kallidinogenase de Deebio pro Varietate morborum cardiovascularium et cerebovascularium
Detail
1. Characteres: Alba vel fere cerussa, olet.
2. Extraction Source: Pancreas Porcine.
3. Processus: Kallidinogenase e sano pancreate porcino extrahitur.
4. Indicationes et usus: Hoc productum adhiberi possunt propter varios morbos cardiovasculares et cerebovasculares, ut morborum cor coronarium, arteriosclerosis cerebri, thrombosis cerebri, sanguinem retinae suppeditant perturbationes et morbum periphericum vascularium.Meliorem effectum therapeuticum in recentibus investigationibus habere pro praeventioni primaeva diabetica microangiopathia et nephropathia diabetica, albumin excretionem minuere potest.Clinica notitia tam domi quam foris suadet ut sperma activitatis et productionis quantitatem augere possit, et aliquem effectum sanativum habet in sterilitate alicuius masculina tractatione.
quare nos?
· Produci in officina GMP
· XXVII annos biologicos enzyme R&D history
· Rudis materia deprauationis
· parere mos vexillum
· Export ut supra XXX regiones et regiones
· Facultatem administrationis qualitatis habet ut FDA, Iaponia PMDA, Corea Meridiana MFDS, etc.
Specification
| Test Items | Societas Specification | ||
| CP | JP | ||
| Characteres | Alba vel fere cerussa, inodora | Alba vel leviter brunneis pulveris, inodora vel languida est | |
| Lepidium sativum | R (hydrolysis rate): 0.12~0.17 | R (hydrolysis rate): 0.12~0.16 | |
| Liquid Chromatography: Conforms | I: ≤ 0.2 | ||
| Tests | pH | 5.5~7.5.300unit/ml. | 5.5~7.5.1g/300ml. |
| Claritas solutionis | Patet.2mg/ml. | ---- | |
| Pinguis | ≤ 5.0mg/g | ≤ 1.0mg/g | |
| Kininase | ---- | R Precium.≥ 0.8 | |
| Trypsin, sicut substantia | ---- | T Pendo.≤ 0.05 | |
| Protease | A280≤ 0.2 | A280≤ 0.2 | |
| Damnum in siccitate | ≤ 5.0% (60℃ Siccum in Vacuo, 4h) | ≤ 2.0% (60℃ Siccum in Vacuo, 4h) | |
| Requiesce in ignitio | ≤ 3.0% | ≤ 3.0% | |
| Kinin-releasing operatio | ---- | ≥ 500ng bradykinin equivalent/min/unit per unit | |
| Puritas | ≥ 75% (oralis) | ---- | |
| ≥ XC% (iniectio) | |||
| Bacterial endotoxin | ≤ 2.5 EU/unitas (iniectio) | ---- | |
| Assay | Enzyme operatio | ---- | ≥ 25 unit/mg |
| Imprimis actio | ≥ 300 unit/mg dapibus (oralis) | ≥ 100 unit/mg protein | |
| ≥ 600 unit/mg interdum (iniectio) | |||
| Microbial immunditias | TAMC | ≤ 1000cfu/g (orali) | ≤ 1000cfu/g |
| ≤ 100cfu/g (iniectio) | |||
| TYMC | ≤ 100cfu/g* | ≤ 100cfu/g* | |
| E.coli | Conforms | Conforms | |
| Salmonella | Conforms | Conforms | |
